Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Moderate to Severe Mitral Stenosis: A Systematic Review

The use of novel oral anticoagulants (NOAC) in patients with moderate to severe mitral stenosis (MS) and atrial fibrillation (AF) is not recommended. We aimed to evaluate the efficacy and safety of NOAC usage compared to vitamin K antagonist (VKA) in patients with moderate to severe MS and AF. We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Rawahi, Mohamed N, Al-Maqbali, Juhaina S, Al Noumani, Jawahar, Al Alawi, Abdullah M, Essebag, Vidal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891397/
https://www.ncbi.nlm.nih.gov/pubmed/36741597
http://dx.doi.org/10.7759/cureus.33222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891397/
https://www.ncbi.nlm.nih.gov/pubmed/36741597
http://dx.doi.org/10.7759/cureus.33222

Ejemplares similares